Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339).
Biomed Pharmacother
2024
170
Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component.
JHEP Rep
2024
6
4
Immunometabolism and viral pathogenesis in hepatitis B virus infection
2024
Dissertation
105 Seiten
Development of mRNA and deficient Sendai Virus vector vaccine against Human Norovirus
2024
Dissertation
99 Seiten
Bedeutung des HLA-B*27-Allels für den Ausgang einer Hepatitis-Delta-Virus-Infektion
2024
Dissertation
94 Seiten
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.
J Clin Virol
2024
170
Generation of multicistronic DNA- and mRNA-based therapeutic vaccines against chronic hepatitis B virus infection
2024
Dissertation
166 Seiten
Evaluation of strategies to increase safety of adoptive T-cell therapy against chronic hepatitis B
2024
Dissertation
126 Seiten
Generation of recombinant MVA encoding HBV core and CD70 and evaluation of the co-stimulatory effect of CD70 in protein-prime/MVA boost vaccination in mice
2024
Dissertation
128 Seiten